396 related articles for article (PubMed ID: 36248991)
1. Radioresistance in rhabdomyosarcomas: Much more than a question of dose.
Camero S; Cassandri M; Pomella S; Milazzo L; Vulcano F; Porrazzo A; Barillari G; Marchese C; Codenotti S; Tomaciello M; Rota R; Fanzani A; Megiorni F; Marampon F
Front Oncol; 2022; 12():1016894. PubMed ID: 36248991
[TBL] [Abstract][Full Text] [Related]
2. Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma.
Pomella S; Porrazzo A; Cassandri M; Camero S; Codenotti S; Milazzo L; Vulcano F; Barillari G; Cenci G; Marchese C; Fanzani A; Megiorni F; Rota R; Marampon F
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362070
[TBL] [Abstract][Full Text] [Related]
3. Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma.
Harel M; Ferrer FA; Shapiro LH; Makari JH
Urol Oncol; 2016 Feb; 34(2):103-15. PubMed ID: 26519985
[TBL] [Abstract][Full Text] [Related]
4. NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.
Marampon F; Codenotti S; Megiorni F; Del Fattore A; Camero S; Gravina GL; Festuccia C; Musio D; De Felice F; Nardone V; Santoro AN; Dominici C; Fanzani A; Pirtoli L; Fioravanti A; Tombolini V; Cheleschi S; Tini P
J Cancer Res Clin Oncol; 2019 Apr; 145(4):881-893. PubMed ID: 30701326
[TBL] [Abstract][Full Text] [Related]
5. Advances in the management of pediatric genitourinary rhabdomyosarcoma.
Deel MD
Transl Androl Urol; 2020 Oct; 9(5):2441-2454. PubMed ID: 33209718
[TBL] [Abstract][Full Text] [Related]
6. Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation.
Perrone C; Pomella S; Cassandri M; Pezzella M; Giuliani S; Gasperi T; Porrazzo A; Alisi A; Pastore A; Codenotti S; Fanzani A; Barillari G; Conti LA; De Angelis B; Quintarelli C; Mariottini P; Locatelli F; Marampon F; Rota R; Cervelli M
Front Cell Dev Biol; 2023; 11():1061570. PubMed ID: 36755974
[TBL] [Abstract][Full Text] [Related]
7. MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.
Cassandri M; Pomella S; Rossetti A; Petragnano F; Milazzo L; Vulcano F; Camero S; Codenotti S; Cicchetti F; Maggio R; Festuccia C; Gravina GL; Fanzani A; Megiorni F; Catanoso M; Marchese C; Tombolini V; Locatelli F; Rota R; Marampon F
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639012
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Rhabdomyosarcomas of the Genitourinary Tract.
Castle JT; Levy BE; Allison DB; Rodeberg DA; Rellinger EJ
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345202
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
10. Soft tissue sarcoma in children: prognosis and management.
Koscielniak E; Morgan M; Treuner J
Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
[TBL] [Abstract][Full Text] [Related]
11. The botanical drug PBI-05204, a supercritical CO
Vaccaro S; Rossetti A; Porrazzo A; Camero S; Cassandri M; Pomella S; Tomaciello M; Macioce G; Pedini F; Barillari G; Marchese C; Rota R; Cenci G; Tombolini M; Newman RA; Yang P; Codenotti S; Fanzani A; Megiorni F; Festuccia C; Minniti G; Gravina GL; Vulcano F; Milazzo L; Marampon F
Front Pharmacol; 2022; 13():1071176. PubMed ID: 36532747
[TBL] [Abstract][Full Text] [Related]
12. BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells.
Camero S; Camicia L; Marampon F; Ceccarelli S; Shukla R; Mannarino O; Pizer B; Schiavetti A; Pizzuti A; Tombolini V; Marchese C; Dominici C; Megiorni F
Cancer Lett; 2020 Jun; 479():71-88. PubMed ID: 32200036
[TBL] [Abstract][Full Text] [Related]
13. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):718-725. PubMed ID: 33516439
[TBL] [Abstract][Full Text] [Related]
14. Interfering with Hedgehog Pathway: New Avenues for Targeted Therapy in Rhabdomyosarcoma.
Manzella G; Schäfer BW
Curr Drug Targets; 2016; 17(11):1228-34. PubMed ID: 25944015
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair.
Codenotti S; Marampon F; Triggiani L; Bonù ML; Magrini SM; Ceccaroli P; Guescini M; Gastaldello S; Tombolini V; Poliani PL; Asperti M; Poli M; Monti E; Fanzani A
Cancer Lett; 2021 May; 505():1-12. PubMed ID: 33610729
[TBL] [Abstract][Full Text] [Related]
16. Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group.
Walterhouse DO; Meza JL; Breneman JC; Donaldson SS; Hayes-Jordan A; Pappo AS; Arndt C; Raney RB; Meyer WH; Hawkins DS
Pediatr Blood Cancer; 2011 Jul; 57(1):76-83. PubMed ID: 21298768
[TBL] [Abstract][Full Text] [Related]
17. Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines.
Giannattasio S; Megiorni F; Di Nisio V; Del Fattore A; Fontanella R; Camero S; Antinozzi C; Festuccia C; Gravina GL; Cecconi S; Dominici C; Di Luigi L; Ciccarelli C; De Cesaris P; Riccioli A; Zani BM; Lenzi A; Pestell RG; Filippini A; Crescioli C; Tombolini V; Marampon F
J Endocrinol Invest; 2019 Feb; 42(2):183-197. PubMed ID: 29790086
[TBL] [Abstract][Full Text] [Related]
18. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Yu L; Wang J
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
[TBL] [Abstract][Full Text] [Related]
19. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
[TBL] [Abstract][Full Text] [Related]
20. Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma.
Shapiro DD; Harel M; Ferrer F; McKenna PH
Int Urol Nephrol; 2016 Jul; 48(7):1009-13. PubMed ID: 27068815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
